Trend

Catalyst Biosciences lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $22.84 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.50% during the next 3 months and, with 90% probability hold a price between $22.04 and $28.73 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Catalyst Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $25.72 and $26.50. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday May 16, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 30 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.86 between high and low, or 3.71%. For the last week, the stock has had a daily average volatility of 7.56%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation

Catalyst Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.